Test-retest reliability of vibration perception threshold test in people with type 2 diabetes mellitus
MetadataShow full item record
Background: Diabetes mellitus is a chronic disease characterized by fasting hyperglycemia. It affects approximately 415 million people worldwide and involves a variety of complications. One of them is the loss of sensitivity to peripheral vibration. Objective: Our study aims to discover the test-retest reliability of a procedure for assessing vibration sensitivity in people with type 2 diabetes mellitus. Methodology: 90 people with type 2 diabetes mellitus (56 men and 34 women) performed the vibration perception threshold (VPT) test using the Vibratron II device. A re-test was completed seven days after the first reading. Results: The relative reliability of the VPT test result is excellent (intraclass correlation coefficient = 0.96). The same applies to gender and obesity subgroups. Regarding absolute reliability, the standard error of measurement is 8.99%, and the small real difference is 24.94%. Conclusions: The relative and absolute reliability results of the vibration perception threshold in people with type 2 diabetes mellitus offer excellent results. © 2020 by the authors. Licensee MDPI, Basel, Switzerland.
Showing items related by title, author, creator and subject.
Acute effects of a whole body vibration session on the vibration perception threshold in patients with type 2 diabetes mellitus (2020) Dominguez-Muñoz F.J.; Hernandez-Mocholi M.A.; Villafaina S.; García-Gordillo M.A.; Collado-Mateo D.; Gusi N.; Adsuar J.C. (MDPI AG, 2020)
Association between TUG and Anthropometric Values, Vibration Perception Threshold, FHSQ and 15-D in Type 2 Diabetes Mellitus Patients (2020) Domínguez-Muñoz F.J.; Adsuar J.C.; Carlos-Vivas J.; Villafaina S.; Garcia-Gordillo M.A.; Hernández-Mocholi M.Á.; Collado-Mateo D.; Gusi N. (NLM (Medline), 2020)
Effects of 8-week whole-body vibration training on the HbA1c, quality of life, physical fitness, body composition and foot health status in people with T2DM: A double-blinded randomized controlled trial (2020) Domínguez-Muñoz F.J.; Villafaina S.; García-Gordillo M.A.; Hernández-Mocholi M.Á.; Collado-Mateo D.; Adsuar J.C.; Gusi N. (MDPI AG, 2020)